Clients Confirm Velesco's Pharmaceutical Development Expertise
From new drug development to analytical testing laboratory services, our clients praise us for our expertise and excellent service. We stand out in a highly competitive world of drug development. We understand the greatest testament to our expertise and service is from our clients themselves.
"Through a collaboration with Velesco, we were able to expand our pilot drug product formulation efforts to achieve a meaningful dosing solution for our exploratory toxicology studies. The combination of their deep formulation development expertise and their agile, transparent work style enabled Velesco to quickly add value to our evolving pharmaceutical research program. The Velesco team really functioned as an extension of our in-house team rather than an external vendor; it’s this type of collaboration and pharmaceutical expertise that’s the most valuable to a lean company like ours."
Executive Director of Development, VC-backed pharma company
"We worked with Velesco on a complicated analytical method and drug formulation project. Velesco stands out with a flexibility and responsiveness that complements their scientific expertise."
"For our program, Velesco performed development work on a challenging analytical method project to measure low levels of active pharmaceutical ingredient (API) and related substances in the presence of many interfering excipients. The project was handled expertly from start to finish. The outstanding features of Velesco’s service are their highly knowledgeable and responsive personnel who provide a very quick turnaround time between discussion and results. I highly recommend Velesco and plan to use their pharmaceutical services in the future."
Director, Technical Operations, pharma company
"Velesco is doing a great job; I'm pleased with how rapidly they are addressing our needs."
CSO, pharma company
"We are very happy with the results of the recently completed drug formulation project."
Director of CMC, pharma company
"The colleagues at Velesco are very professional scientists. We do not feel as though they are just another contract research organization (CRO), we feel they are drug development partners that truly help in resolving issues."
Executive Director, pharma company
"Velesco cracked the case for a formulation/analytics problem that had plagued a drug development company I was working with for months. Within a week of being brought on board they diagnosed the problem and found a solution that was immediately implementable to the drug manufacturing protocol. We were able to move forward with producing clinical trial materials that would have otherwise delayed the start of the clinical study. It was truly a magical, rabbit-out-of-a-hat performance. Thanks Velesco!"
CEO, business consulting firm
News and Events
Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services
Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now. View Recording!
Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.
New Velesco Pharma clinical manufacturing facility begins operations. Read the press release here.
Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing. Read the interview here.
Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group. Read the press release here.
CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!
1 new job postings! Careers
Velesco's work published
Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.